doi: 10.1016/0014-2999(92)90732-j.
NG-nitro-L-arginine prevents morphine tolerance
Affiliations
- PMID: 1426018
- DOI: 10.1016/0014-2999(92)90732-j
Item in Clipboard
NG-nitro-L-arginine prevents morphine tolerance
Eur J Pharmacol.
.
Abstract
NMDA receptor antagonists, such as MK-801, prevent the development of tolerance to morphine. Since many NMDA actions involve the production of nitric oxide, we examined the effects of a nitric oxide synthase inhibitor on morphine tolerance. The analgesic response to morphine (5 mg/kg s.c.) given daily diminishes from 60% in naive animals to 0% within 5 days. Coadministration of NG-nitro-L-arginine (8 mg/kg per day) along with morphine prevents the demonstration of appreciable tolerance for at least 11 days. These results suggest that morphine tolerance involves the activation of NMDA receptors followed by the subsequent release of nitric oxide.
Similar articles
-
The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.Pain. 1994 Jan;56(1):69-75. doi: 10.1016/0304-3959(94)90151-1. Pain. 1994. PMID: 7512709
-
Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor.Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5162-6. doi: 10.1073/pnas.90.11.5162. Proc Natl Acad Sci U S A. 1993. PMID: 7685116 Free PMC article.
-
Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice.Neuropharmacology. 1994 Feb;33(2):189-92. doi: 10.1016/0028-3908(94)90006-x. Neuropharmacology. 1994. PMID: 7518573
-
Perspectives on the N-methyl-D-aspartate/nitric oxide cascade and opioid tolerance.Neuropsychopharmacology. 1995 Dec;13(4):309-13. doi: 10.1016/0893-133X(95)00084-Q. Neuropsychopharmacology. 1995. PMID: 8747755 Review.
-
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.Neuropsychopharmacology. 1995 Dec;13(4):315-22. doi: 10.1016/0893-133X(95)00138-4. Neuropsychopharmacology. 1995. PMID: 8747756 Review.
Cited by
-
The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.Neurotox Res. 2002 Jun;4(4):373-91. doi: 10.1080/10298420290023954. Neurotox Res. 2002. PMID: 12829426
-
Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance.Br J Pharmacol. 1999 Jun;127(3):631-44. doi: 10.1038/sj.bjp.0702587. Br J Pharmacol. 1999. PMID: 10401553 Free PMC article.
-
Nitric oxide.Ann Rheum Dis. 1996 Jan;55(1):7-20. doi: 10.1136/ard.55.1.7. Ann Rheum Dis. 1996. PMID: 8572740 Free PMC article. Review. No abstract available.
-
Inhibition of Spinal Oxidative Stress by Bergamot Polyphenolic Fraction Attenuates the Development of Morphine Induced Tolerance and Hyperalgesia in Mice.PLoS One. 2016 May 26;11(5):e0156039. doi: 10.1371/journal.pone.0156039. eCollection 2016. PLoS One. 2016. PMID: 27227548 Free PMC article.
-
Peroxynitrite and opiate antinociceptive tolerance: a painful reality.Arch Biochem Biophys. 2009 Apr 15;484(2):238-44. doi: 10.1016/j.abb.2008.11.005. Epub 2008 Nov 11. Arch Biochem Biophys. 2009. PMID: 19017525 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
